Propanc Biopharma, Inc. (PPCB)
NASDAQ: PPCB · Real-Time Price · USD
0.2278
-0.0501 (-18.03%)
At close: Jan 30, 2026, 4:00 PM EST
0.2244
-0.0034 (-1.49%)
After-hours: Jan 30, 2026, 7:59 PM EST

Propanc Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jan '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
348010-
Market Cap Growth
-11514.72%-25.62%26.73%--
Enterprise Value
349111-
Last Close Price
0.234.1574.858083.83220059.883095808.38
PB Ratio
0.203.47-0.11-0.18-0.15-
P/TBV Ratio
0.213.47----
Debt / Equity Ratio
0.050.12-0.25-0.17-0.34-0.22
Quick Ratio
0.170.000.010.000.000.00
Current Ratio
2.451.500.010.010.010.00
Return on Equity (ROE)
-1236.83%-1163.67%----
Return on Assets (ROA)
-427.27%-363.36%-1447.01%-1564.19%-2626.42%-2029.40%
Return on Capital Employed (ROCE)
-428.10%-407.60%41.30%57.30%66.80%59.10%
Earnings Yield
-2082.75%-122.28%-438.79%-476.99%-603.95%-
FCF Yield
-69.35%-0.84%-225.39%-198.15%-326.34%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.